Bio-Techne Corporation (TE1.F)
| Previous close | 71.50 |
| Open | 70.00 |
| Bid | 71.50 x N/A |
| Ask | 71.50 x N/A |
| Day's range | 70.00 - 70.00 |
| 52-week range | 49.40 - 80.50 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 11.003B |
| Beta (5Y monthly) | 1.22 |
| PE ratio (TTM) | 59.83 |
| EPS (TTM) | 1.17 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | 0.30 (0.42%) |
| Ex-dividend date | 10 May 2024 |
| 1y target est | 549.60 |
PR NewswireBIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its portfolio of cell and gene therapy workflow solutions at the upcoming annual meeting of the American Society of Gene & Cell Therapy (ASGCT), taking place May 7-11, 2024, in Baltimore, Maryland.
Simply Wall St.Bio-Techne Corporation Just Recorded A 7.6% EPS Beat: Here's What Analysts Are Forecasting Next
Bio-Techne Corporation ( NASDAQ:TECH ) defied analyst predictions to release its quarterly results, which were ahead of...
Insider MonkeyBio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript
Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript May 1, 2024 Bio-Techne Corporation beats earnings expectations. Reported EPS is $0.48, expectations were $0.46. Bio-Techne Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the Bio-Techne […]
